Skip to content
← KPV

30 mg vial

KPV 30 mg vial: how to reconstitute it

What a 30 mg vial of KPV becomes once it is mixed, and what each dose reported in the sources draws to on a syringe. Every figure is arithmetic on the vial size in the heading — none of it is a recommendation, and the doses are the ones our sources describe rather than ones we picked.

Leading with

30 mg + 1 mL bacteriostatic water = 30 mg/mL

Chosen because it puts the reported doses on readable marks of a 1 mL U-100 syringe. Other volumes are perfectly valid — the dilution table further down covers them, and the concentration changes what every dose draws to.

What each reported dose draws to

At 30 mg/mL, on a 1 mL U-100 syringe. Every row names the source it came from, and a trial protocol and a community convention are not the same kind of information.

Reported doses for KPV, converted to syringe units for a 30 mg vial.
GoalDoseUnitsDoses in this vialSource
Commonly described doseOnce daily · Subcutaneous200 mcg – 500 mcg0.67 units – 1.67 units150Community practice
As delivered within a KLOW blendOnce daily · Subcutaneous250 mcg – 400 mcg0.83 units – 1.33 units120Community practice

Check every figure against the vial in front of you before drawing. Vials are filled with an overage and labels are not a guarantee. Change any of these numbers in the calculator.

Week by week

Published schedules only. Most compounds on this site have no week-by-week schedule from any source, and where that is the case this section does not appear rather than being filled in.

Reported community progression

Community practice
Reported community progression for KPV, with the syringe units for a 30 mg vial.
WeekDoseUnitsFrequency
1200 mcg0.67 unitsOnce daily
2300 mcg1 unitOnce daily
3400 mcg1.33 unitsOnce daily
4–8500 mcg1.67 unitsOnce daily

A progression described in community sources, not a finding. No dose-ranging study establishes these steps, and the compilation they come from contained arithmetic errors in its own syringe figures — so the doses are reproduced and none of its unit conversions are.

What the whole schedule costs

Vials of this size needed to work through each step, at 1 mL per vial. The dose changes as you go, so this is not one number times a number of weeks — it is each step costed separately and added up.

Reported community progression

Vials of 30 mg needed for each step of Reported community progression.
WeekDoseDoses30 mg vials
1200 mcg71
2300 mcg71
3400 mcg71
4–8500 mcg351

Reaching the end of the defined steps takes 4 vials of 30 mg over 8 weeks.

Steps whose dose exceeds this vial are marked rather than counted — at that point a larger vial is the answer, not more small ones. Nothing here accounts for a dropped vial, a held step or a dose your prescriber changes, all of which happen.

If you add a different amount of water

The same 30 mg of compound, at four common volumes. More water means a larger, easier-to-measure draw of a weaker solution; less water means the opposite. The amount of compound you inject is identical in every row — only the volume carrying it changes.

Concentration and draw volume for a 30 mg vial at four water volumes.
Water addedConcentration200 mcg draws to
1 mLshown above30 mg/mL0.67 units units · 0.007 mL
2 mL15 mg/mL1.33 units units · 0.013 mL
3 mL10 mg/mL2 units units · 0.02 mL
5 mL6 mg/mL3.33 units units · 0.033 mL

Storage

Before mixing

Refrigerated at 2–8 °C, protected from light.

After mixing

Refrigerated at 2–8 °C. Do not freeze once mixed.

Other vial sizes

The same compound, different arithmetic.

Arithmetic on the vial size named above and the doses our sources report. Nothing here is a recommendation, a protocol or medical advice, and no clinician has reviewed it. Some rows describe community practice, which is not evidence that a dose is safe or effective. Speak to a licensed healthcare provider before acting on any of it.

Sources for the doses above are listed in full on the KPV profile, each with the trial or label it came from.